China, Sept. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Erythrocyte Enriched Multifunctional Metabolite R1 in Patients with Acute Ischemic Stroke'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133298
Registration Time: 2026/09/23
Type: Interventional study
Primary Sponsor: Xiangya Hospital Central South University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343221
Published by HT Digital Content Services with permission from Health Daily Digest....